Intera Oncology
Kathryn Muller currently serves as a Fellow in Clinical Science Marketing at Intera Oncology Inc., focusing on translating clinical evidence into strategic programs to enhance the adoption of hepatic artery infusion therapy since August 2023. Prior to this, Kathryn operated as the Sole Proprietor at PROVA Evidence-Based Marketing LLC for eight years, assisting medical and biotech companies in crafting effective messaging based on clinical and economic data. Kathryn held the position of Senior Fellow and Director of Clinical Marketing at Maquet Cardiovascular for eight years, where relationships with key customers and thought leaders were cultivated. Earlier experience includes an advisory role at Guidant Cardiac Surgery and a managerial position in Clinical Marketing at CardioThoracic Systems. Kathryn earned a Doctor of Philosophy (PhD) in Psychology from Stanford University and a Bachelor of Arts (B.A.) in Psychology from the University of Connecticut.
This person is not in any teams
This person is not in any offices
Intera Oncology
1 followers
Intera Oncology specializes in improving the survival of colorectal cancer and cholangiocarcinoma patients. It acquires Oncology and Neuromodulation Drug Delivery products from Johnson & Johnson where they entered an agreement for the sale of the Drug Delivery Oncology/Neuromodulation business to Intera Oncology. This includes accessoriesfor Codman 3000, MedStream, and Model 400/500 pumps.It was founded in 2019 and is headquartered in Wellesley, Massachusetts.